The Future of Immuno-Oncology: Perspectives from Academia and Industry

September 19, 2014


  • Jeffrey M. Bockman, PhD, Executive Vice President, Head of Oncology Practice, Defined Health


  • Axel Hoos, Vice President of Oncology Research and Development at GSK
  • Drew Pardoll, Abeloff Professorship of Oncology and Director of Cancer Immunology at Johns Hopkins University